Published in J Mol Cell Cardiol on May 01, 1995
Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation (2000) 6.56
Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med (1978) 3.42
"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol (1978) 3.26
Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet (1983) 2.70
Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med (1987) 2.54
Inferior vena cava-pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg (1990) 2.25
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation (1999) 2.00
Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost (1996) 1.83
Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol (2000) 1.70
Interaction between photosystem I and ferredoxin. Identification by chemical cross-linking of the polypeptide which binds ferredoxin. Eur J Biochem (1987) 1.58
Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest (1982) 1.57
A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost (2001) 1.57
Sequence of events in angina at rest: primary reduction in coronary flow. Circulation (1980) 1.51
Coronary artery spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis (1983) 1.47
Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J Biol Chem (1997) 1.45
The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res (1999) 1.44
Frequency of factor V Arg506 Gln in Italians. Thromb Haemost (1996) 1.39
Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J (2000) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol (1983) 1.35
Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol (2002) 1.31
Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations. N Engl J Med (1984) 1.28
Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol (1998) 1.23
Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol (1998) 1.22
Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation (1986) 1.21
Role of heme oxygenase-1 in hypoxia-reoxygenation: requirement of substrate heme to promote cardioprotection. Am J Physiol Heart Circ Physiol (2001) 1.13
Atrioventricular canal in Down syndrome. Prevalence of associated cardiac malformations compared with patients without Down syndrome. Am J Dis Child (1990) 1.12
Nutritional status and dietary patterns in disabled people. Nutr Metab Cardiovasc Dis (2005) 1.12
Body composition assessment in spinal cord injury subjects. Acta Diabetol (2003) 1.11
alpha-Adrenergic receptors and coronary spasm: an elusive link. Circulation (1984) 1.08
Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis. Biochem J (1999) 1.08
Treatment with CO-RMs during cold storage improves renal function at reperfusion. Kidney Int (2006) 1.07
Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. Am J Cardiol (1985) 1.07
Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod (1999) 1.04
Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation (1986) 1.04
Significance of spasm in the pathogenesis of ischemic heart disease. Am J Cardiol (1979) 0.99
Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol (1998) 0.98
Wearable seismocardiography: towards a beat-by-beat assessment of cardiac mechanics in ambulant subjects. Auton Neurosci (2013) 0.98
Role of heart rate in pathophysiology of chronic stable angina. Lancet (1984) 0.96
Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart. Br J Pharmacol (2006) 0.93
Carbon monoxide-releasing molecules (CO-RMs) modulate respiration in isolated mitochondria. Cell Mol Biol (Noisy-le-grand) (2005) 0.93
Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations. Am Heart J (1981) 0.92
Induction of coronary artery spasm by a direct local action of ergonovine. Circulation (1987) 0.91
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol (2000) 0.91
Involvement of the heme oxygenase-carbon monoxide pathway in keratinocyte proliferation. Biochem Biophys Res Commun (1997) 0.91
Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med (2001) 0.89
The role of alpha-adrenergic receptors in the pathogenesis of coronary spasm. Clin Cardiol (1983) 0.89
Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. Am J Physiol (1998) 0.89
Human red cell age, oxygen affinity and oxygen transport. Respir Physiol (1990) 0.88
Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol (1986) 0.88
Effects of intravenous prostacyclin in variant angina. Circulation (1982) 0.88
Limitations of dipyridamole-echocardiography in effort angina pectoris. Am J Cardiol (1987) 0.88
Mixed angina pectoris. Am J Cardiol (1985) 0.88
Genetic risk factors in young adults with 'cryptogenic' ischemic cerebrovascular disease. Blood Coagul Fibrinolysis (2002) 0.87
Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol (1999) 0.87
Total extracardiac right heart bypass. Circulation (1992) 0.87
Pathophysiology of coronary occlusion in acute infarction. Circulation (1986) 0.86
Inhibition of platelet function by injectable isosorbide dinitrate. Am J Cardiol (1984) 0.86
Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. Thromb Res (2012) 0.86
Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis. Ann Rheum Dis (2007) 0.86
Habitual snoring as a risk factor for acute vascular disease. Eur Respir J (1993) 0.86
Prostacyclin does not affect insulin secretion in humans. Prostaglandins (1981) 0.86
Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts. Cardiovasc Drugs Ther (1998) 0.85
Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: Are early and one-year results different? Catheter Cardiovasc Interv (2001) 0.85
The comparative effects of the NOS inhibitor, Nomega-nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow. Int J Radiat Oncol Biol Phys (1998) 0.85
Seveso Women's Health Study: does zone of residence predict individual TCDD exposure? Chemosphere (2001) 0.84
Continuous monitoring of the sympatho-vagal balance through spectral analysis. IEEE Eng Med Biol Mag (1997) 0.84
Ergonovine-induced myocardial ischemia: no role for serotonergic receptors? Circulation (1984) 0.84
Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: involvement of the transcription factor Nrf2. Cell Mol Biol (Noisy-le-grand) (2002) 0.84
The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood (1997) 0.84
Carbon monoxide reduces the expression and activity of matrix metalloproteinases 1 and 2 in alveolar epithelial cells. Cell Mol Biol (Noisy-le-grand) (2005) 0.84
Reviewing the use of carbon monoxide-releasing molecules (CO-RMs) in biology: implications in endotoxin-mediated vascular dysfunction. Cell Mol Biol (Noisy-le-grand) (2005) 0.84
Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease. Circulation (1997) 0.83
Inappropriate sinus tachycardia after radiofrequency ablation of para-Hisian accessory pathways. J Cardiovasc Electrophysiol (1997) 0.82
Drug-induced in vitro inhibition of neutrophil-endothelial cell adhesion. Br J Pharmacol (1996) 0.82
A histidine to tyrosine replacement in lysosomal acid lipase causes cholesteryl ester storage disease. Hum Mol Genet (1994) 0.82
CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. Br J Pharmacol (2014) 0.82
Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina. Circulation (1982) 0.82
Coronary vasospasm in ischemic heart disease. Chest (1980) 0.82
Parental transmission of congenital heart disease. Am J Cardiol (1989) 0.82
Computer system for analysis of ST segment changes on 24 hour Holter monitor tapes: comparison with other available systems. J Am Coll Cardiol (1984) 0.82
Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation. Cryobiology (2009) 0.81
Genetics of renal damage in primary hypertension. Am J Kidney Dis (1993) 0.81
Human red blood cell aging at 5,050-m altitude: a role during adaptation to hypoxia. J Appl Physiol (1985) (1993) 0.81
Effects of short term cast wearing on respiratory and cardiac responses to submaximal and maximal exercise in adolescents with idiopathic scoliosis. Eura Medicophys (2005) 0.81
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol (2011) 0.81
Univentricular heart: can we alter the natural history? Ann Thorac Surg (1982) 0.81
Oxidative injury in reoxygenated and reperfused hearts. Free Radic Biol Med (1994) 0.81
Nutritional counselling in disabled people: effects on dietary patterns, body composition and cardiovascular risk factors. Eur J Phys Rehabil Med (2008) 0.81
Cardiac rhabdomyoma: surgical treatment in the neonate. J Thorac Cardiovasc Surg (1984) 0.81
Bidirectional cavopulmonary shunts: clinical applications as staged or definitive palliation. Ann Thorac Surg (1989) 0.81
Heart adaptations to long-term aerobic training in paraplegic subjects: an echocardiographic study. Spinal Cord (2012) 0.81
Homocysteine attenuates endothelial haem oxygenase-1 induction by nitric oxide (NO) and hypoxia. FEBS Lett (2001) 0.81
Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene. Toxicol Lett (2009) 0.81
Unusual combination of congenital heart lesions in a child with Noonan's syndrome. Pediatr Cardiol (1982) 0.81
Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol (1997) 0.81